SWIM816

· Stemirna Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SWIM816, covering 2023-06-20 to 2023-06-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 [Phase 2, Phase 3]

See pricing